FTD patients with anti-GluA3 antibody had presenile onset (<65 y/o) in 66% of the cases (27/41), 63.4% presented bvFTD (26/41) and 95.2% had no evidence of autosomal dominant inheritance (39/41). The gene discussed is GRIA3; the disease is frontotemporal dementia.